Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,273 | 349 | 72.5% |
| Travel and Lodging | $2,077 | 8 | 20.7% |
| Education | $688.57 | 14 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,716 | 66 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $1,368 | 7 | $0 (2024) |
| Boston Scientific Corporation | $1,274 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $1,198 | 39 | $0 (2024) |
| ABBVIE INC. | $604.78 | 36 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $529.65 | 15 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $494.86 | 22 | $0 (2024) |
| Allergan, Inc. | $227.10 | 15 | $0 (2020) |
| Rochester Medical Corporation | $223.97 | 18 | $0 (2022) |
| PFIZER INC. | $223.59 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,763 | 68 | PROCEPT BioRobotics Corporation ($1,368) |
| 2023 | $1,672 | 65 | Janssen Biotech, Inc. ($271.47) |
| 2022 | $1,344 | 28 | Boston Scientific Corporation ($837.91) |
| 2021 | $3.82 | 1 | Travere Therapeutics, Inc. ($3.82) |
| 2020 | $493.85 | 25 | Astellas Pharma US Inc ($176.93) |
| 2019 | $1,446 | 73 | Astellas Pharma US Inc ($390.53) |
| 2018 | $1,440 | 66 | Astellas Pharma US Inc ($410.46) |
| 2017 | $874.87 | 45 | Janssen Biotech, Inc. ($257.46) |
All Payment Transactions
371 individual payment records from CMS Open Payments — Page 2 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/08/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $229.02 | General |
| Category: UROLOGY | ||||||
| 06/08/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $45.00 | General |
| Category: UROLOGY | ||||||
| 06/08/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| Category: UROLOGY | ||||||
| 06/08/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: rezum_URO | ||||||
| 06/08/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $4.57 | General |
| Category: UROLOGY | ||||||
| 06/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Oncology | ||||||
| 05/22/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Immunotherapy | ||||||
| 05/21/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.37 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.51 | General |
| 05/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/30/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $14.11 | General |
| 04/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/22/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $515.19 | General |
| Category: UROLOGY | ||||||
| 04/22/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $515.19 | General |
| Category: UROLOGY | ||||||
| 04/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $91.73 | General |
| Category: UROLOGY | ||||||
| 04/16/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Urology | ||||||
| 04/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/02/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.79 | General |
| Category: UROLOGY | ||||||
| 03/28/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/26/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $25.57 | General |
| Category: Prostate cancer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,762 | 3,538 | $544,575 | $138,375 |
| 2022 | 23 | 1,825 | 4,394 | $499,134 | $127,293 |
| 2021 | 24 | 1,696 | 4,447 | $494,111 | $141,031 |
| 2020 | 18 | 1,504 | 2,340 | $341,144 | $106,498 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 344 | $111,800 | $29,856 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 284 | 344 | $79,464 | $21,213 | 26.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 88 | 109 | $68,997 | $17,505 | 25.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 116 | $56,608 | $15,768 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 105 | 105 | $44,520 | $11,968 | 26.9% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 14 | 14 | $35,000 | $7,304 | 20.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 18 | 18 | $25,200 | $5,828 | 23.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 19 | 20 | $16,620 | $4,376 | 26.3% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 11 | 1,250 | $6,500 | $2,839 | 43.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $9,975 | $2,370 | 23.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 19 | 21 | $10,625 | $2,318 | 21.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $9,375 | $2,268 | 24.2% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 25 | 48 | $9,600 | $2,053 | 21.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 357 | 504 | $12,600 | $1,973 | 15.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,763 | $1,692 | 29.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 16 | 16 | $8,464 | $1,675 | 19.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 45 | 46 | $6,624 | $1,605 | 24.2% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 11 | 22 | $4,950 | $1,481 | 29.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 112 | 126 | $6,930 | $926.32 | 13.4% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 83 | 105 | $3,675 | $830.55 | 22.6% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 60 | 78 | $3,120 | $661.37 | 21.2% |
| 87088 | Bacterial urine culture | Office | 2023 | 61 | 80 | $2,800 | $634.40 | 22.7% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 61 | 79 | $2,765 | $625.68 | 22.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 26 | $2,600 | $603.62 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 319 | 421 | $97,237 | $25,082 | 25.8% |
About Dr. Bradley Warner, M.D
Dr. Bradley Warner, M.D is a Urology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1417100405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Warner, M.D has received a total of $10,038 in payments from pharmaceutical and medical device companies, with $2,763 received in 2024. These payments were reported across 371 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,273).
As a Medicare-enrolled provider, Warner has provided services to 6,787 Medicare beneficiaries, totaling 14,719 services with total Medicare billing of $513,196. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Salem, OR
- Active Since 11/04/2008
- Last Updated 03/10/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1417100405
Products in Payments
- AQUABEAM SYSTEM (Device) $1,368
- GreenLight XPS (Device) $837.91
- XTANDI (Drug) $743.24
- Erleada (Drug) $536.84
- PROVENGE (Drug) $494.86
- BOTOX (Biological) $486.03
- Myrbetriq (Drug) $415.47
- ZYTIGA (Drug) $380.97
- ERLEADA (Drug) $348.51
- GEMTESA (Drug) $295.60
- ORGOVYX (Drug) $271.78
- MYRBETRIQ (Drug) $245.01
- ELIGARD (Drug) $206.44
- LYNPARZA (Drug) $192.95
- REZUM (Device) $181.93
- Nubeqa (Drug) $118.05
- Xtandi (Drug) $115.20
- BOTOX THERAPEUTIC (Biological) $112.92
- YONSA (Drug) $97.00
- FIRMAGON (Drug) $96.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salem
Dr. Mark Laspina, D.o, D.O
Urology — Payments: $19,777
Stuart Diamond, Md, MD
Urology — Payments: $18,471
Dr. Alejandra Balen, M.d, M.D
Urology — Payments: $14,486
Mr. Noel Defelippo, Md, MD
Urology — Payments: $8,224
Dr. John Mhoon, M.d, M.D
Urology — Payments: $7,907
Mr. Thomas Kingston, Md, MD
Urology — Payments: $6,356